[1]
S. Abzaliyeva, “ «SGLT2 INHIBITORS: RATIONALE FOR THE USE IN HEART FAILURE», RESOLUTION ON THE RESULTS OF THE PANEL OF EXPERTS WITH INTERNATIONAL PARTICIPATION, ALMATY”, Medicine, vol. 3, no. 2, pp. 38–42, Dec. 2022.